5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.38▲ | 1.37▲ | 1.38▲ | 1.37▲ | 1.44▼ |
MA10 | 1.37▲ | 1.38▲ | 1.37▲ | 1.38▲ | 1.64▼ |
MA20 | 1.38▲ | 1.37▲ | 1.35▲ | 1.43▼ | 1.66▼ |
MA50 | 1.36▲ | 1.35▲ | 1.36▲ | 1.71▼ | 1.80▼ |
MA100 | 1.35▲ | 1.37▲ | 1.42▼ | 1.67▼ | 1.74▼ |
MA200 | 1.36▲ | 1.46▼ | 1.56▼ | 1.78▼ | 2.07▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.001▼ | 0.000▲ | 0.004▲ | 0.011▲ | -0.047▼ |
RSI | 52.860▲ | 54.921▲ | 53.776▲ | 44.408▼ | 41.225▼ |
STOCH | 68.056 | 52.189 | 65.704 | 25.862 | 9.853▼ |
WILL %R | -37.500 | -45.455 | -31.250 | -59.214 | -91.848▼ |
CCI | 46.667 | 20.952 | 60.056 | -8.611 | -95.831 |
Tuesday, September 16, 2025 05:15 AM
First data on treatment of NPC1 with Trappsol® Cyclo™ (hydroxypropyl-beta-cyclodextrin) in this age group over a period of 48 weeks At 48 weeks of the sub-study, 7 of 9 patients1 showed stabilization ...
|
Wednesday, August 27, 2025 01:00 AM
NEWARK, N.J., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc. (NYSE: RFL; NYSE American: RFL-WT) announced today that its subsidiary Cyclo Therapeutics has had two abstracts selected for ...
|
Wednesday, August 20, 2025 10:44 AM
Sport England have held what they described as ‘constructive’ meetings with the Rugby Football League over concerns surrounding the sport’s governance: and have requested the governing body produces ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
17/09/25 | 1.44 | 1.47 | 1.35 | 1.41 | 150,425 |
16/09/25 | 1.33 | 1.4763 | 1.325 | 1.42 | 218,304 |
15/09/25 | 1.42 | 1.42 | 1.32 | 1.33 | 176,826 |
12/09/25 | 1.34 | 1.37 | 1.32 | 1.34 | 161,091 |
11/09/25 | 1.36 | 1.4369 | 1.33 | 1.33 | 100,087 |
10/09/25 | 1.50 | 1.51 | 1.32 | 1.33 | 120,732 |
09/09/25 | 1.35 | 1.44 | 1.32 | 1.44 | 178,039 |
08/09/25 | 1.45 | 1.45 | 1.30 | 1.34 | 265,819 |
05/09/25 | 1.49 | 1.49 | 1.41 | 1.44 | 78,215 |
04/09/25 | 1.54 | 1.54 | 1.43 | 1.45 | 105,427 |
|
|
||||
|
|
||||
|
|